Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. International Journal of Endocrinology and Metabolism
  4. Articles

  5. Orlistat Abolishes Postprandial Lipid Peaking
  6. Scopus by Title (Ref)

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Home
Current IssueAll IssuesIn PressSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss

- Rodríguez-Valle A. , et al.

2. Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss

- Rodríguez-Valle A. , et al.

3. The effect of orlistat on postprandial hypertriglyceridemia by oral fat loading test. A systematic review

- Rodríguez-Valle A. , et al.

4. Convergent synthesis of panclicin-D via intramolecular SN2 displacement approach

- Yadav J. , et al.

5. Postprandial effect of orlistat on the peaking of lipid level after sequential high fat meals

- Gabriel F.S. , et al.

6. Postprandial peaking and plateauing of triglycerides and VLDL in patients with underlying cardiovascular diseases despite treatment

- Samson C.E. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.